Glavine Paul purchased $1.2M of HELP
Glavine Paul (Chief Growth Officer) purchased 100,000 shares of CYBIN INC. (HELP) at $11.78 ($1.18M total) on 2026-09-03.
How this was made
The 30-second read
Why it matters
The purchase adds to insider confidence metrics and may influence short‑term trading decisions.
Market read
Insider purchase of a micro‑cap biotech can prompt short‑term price movement.
What to watch
Potential upcoming clinical trial data or partnership announcements not disclosed yet.
Background
Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
Chief Growth Officer Glavine Paul bought 100,000 shares of Cybin Inc. for $1.18M, increasing his stake to over 4 million shares.
Potential modest price uptick as market views the buy as a bullish signal.
The purchase size is notable for a micro‑cap biotech and the insider holds a senior growth role, suggesting belief in upcoming catalysts.
Market effects
May lift sentiment in the biotech sector as insider buying is viewed positively.
Limited to US biotech investors.
Low global impact.
Counterpoint
Insider buying could be a routine portfolio rebalancing, not a catalyst.
Key entities
- CompanyCybin Inc.
US‑listed biotech (ticker HELP).
- ExecutiveGlavine Paul
Chief Growth Officer of Cybin Inc.